Literature DB >> 32416414

Genetic predisposition models to COVID-19 infection.

Farzaneh Darbeheshti1, Nima Rezaei2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32416414      PMCID: PMC7202332          DOI: 10.1016/j.mehy.2020.109818

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


× No keyword cloud information.
A wide range of disease severity among patients with coronavirus disease (COVID-19) has attracted scientists’ attention worldwide. Development of severe symptoms in some adults without any underlying diseases is a challenge. Herein, we explain the potential “genetic predisposition models” to COVID-19 infection with particular emphasis on hypothesizing the possibility of moderately rare dominant variants in severe cases without any underlying medical conditions. Three genetic-related models for predisposition to COVID-19 could be described: 1-Common variants in multiple loci that have weak effect through single contribution. However, they might manifest significant effect through additive contribution in specific individuals to increase infection risk and severity. 2-Moderately rare variants in limited genes are expected to have strong effects, and thus be highly penetrant and even dominant trait as long as COVID-19 infection is considered. These variants could underlie severe forms in young patients without any other medical conditions. 3-Gene-environment interactions define host predisposition. The concept of susceptibility to COVID-19 is getting more and more complex when gene interactions with environment factors, such as smoking, are considered (see Fig. 1 ).
Fig. 1

Schematic visualization of genetic predisposition of COVID-19 infection. Risk of sex difference is not considered. The number of individuals is not to scale.

Schematic visualization of genetic predisposition of COVID-19 infection. Risk of sex difference is not considered. The number of individuals is not to scale. In order to reach more specific and sensitive results of indecisive variants, the assessment of targeted genes could be preferred. The receptor-binding domain (RBD) of the COVID-19 spike-protein shows strong interaction with human angiotensin-converting enzyme 2 (ACE2) receptor. It is assumed that the virus binds to ACE2 to enter cells. Consequently, ACE2 genetic variants that could affect its gene expression, protein conformation, and protein stability are the one of most questionable underlying factors involving in genetic predisposition to COVID-19 infection [1]. ACE2 is an X-linked gene that harbours a strong variant with tendency to X-linked dominant inheritance pattern in severely affected patients. It might be a clue to the higher prevalence and severity of COVID-19 in men than in women [2]. The immune-related genetic variants involving the prior strain of coronavirus, namely SARS-CoV, are suspected to have roles in genetic predisposition of COVID-19 infection [3], [4], since COVID-19 has 80% genetic identity to SARS-CoV [5]. Notably, Mannose-Biding Lectin, CD147, CCL2, Interleukin-12, and HLA genes should be considered [6], [7], [8], [9]. COVID-19 appears to be less severe in children [10]. However, severe illness is seldom developed in children. Being detected DNA-driven interplay points and prospective rare dominant variants could shed light on this mystery. Definitely, the outcome of genetic variants inspection will be a pivotal step to help personalized and predictive medicine in high-risk individuals for severe COVID-19 infection.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  9 in total

1.  Case Report: Death due to COVID-19 in Three Brothers.

Authors:  Sedigheh Yousefzadegan; Nima Rezaei
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  Association of HLA class I with severe acute respiratory syndrome coronavirus infection.

Authors:  Marie Lin; Hsiang-Kuang Tseng; Jean A Trejaut; Hui-Lin Lee; Jun-Hun Loo; Chen-Chung Chu; Pei-Jan Chen; Ying-Wen Su; Ken Hong Lim; Zen-Uong Tsai; Ruey-Yi Lin; Ruey-Shiung Lin; Chun-Hsiung Huang
Journal:  BMC Med Genet       Date:  2003-09-12       Impact factor: 2.103

3.  Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations.

Authors:  Yanan Cao; Lin Li; Zhimin Feng; Shengqing Wan; Peide Huang; Xiaohui Sun; Fang Wen; Xuanlin Huang; Guang Ning; Weiqing Wang
Journal:  Cell Discov       Date:  2020-02-24       Impact factor: 10.849

4.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

5.  Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection.

Authors:  Xinyi Tu; Wai Po Chong; Yun Zhai; Hongxing Zhang; Fang Zhang; Shixin Wang; Wei Liu; Maoti Wei; Nora Ho On Siu; Hao Yang; Wanling Yang; Wuchun Cao; Yu Lung Lau; Fuchu He; Gangqiao Zhou
Journal:  J Infect       Date:  2015-03-27       Impact factor: 6.072

6.  IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese.

Authors:  Fang Tang; Wei Liu; Fang Zhang; Zhong-Tao Xin; Mao-Ti Wei; Pan-He Zhang; Hong Yang; Hinh Ly; Wu-Chun Cao
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

7.  COVID-19 affects healthy pediatricians more than pediatric patients.

Authors:  Nima Rezaei
Journal:  Infect Control Hosp Epidemiol       Date:  2020-04-16       Impact factor: 3.254

Review 8.  Immune-epidemiological parameters of the novel coronavirus - a perspective.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Expert Rev Clin Immunol       Date:  2020-04-06       Impact factor: 4.473

9.  Sex difference and smoking predisposition in patients with COVID-19.

Authors:  Hua Cai
Journal:  Lancet Respir Med       Date:  2020-03-11       Impact factor: 30.700

  9 in total
  33 in total

1.  Nutrition and Immunity in COVID-19.

Authors:  Marjan Moallemian Isfahani; Zahra Emam-Djomeh; Idupulapati M Rao; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

Review 3.  Geriatrics and COVID-19.

Authors:  Mona Mirbeyk; Amene Saghazadeh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Interdisciplinary Approaches to COVID-19.

Authors:  Negar Moradian; Marjan Moallemian; Farnaz Delavari; Constantine Sedikides; Carlos A Camargo; Pedro J Torres; Armin Sorooshian; Saeid Paktinat Mehdiabadi; Juan J Nieto; Stephane Bordas; Hamid Ahmadieh; Mohammad Abdollahi; Michael R Hamblin; Frank W Sellke; Jack Cuzick; Bozkurt Biykem; Michael Schreiber; Babak Eshrati; Georg Perry; Ali Montazeri; Ali Akbar Saboury; Roya Kelishadi; Amirhossein Sahebkar; Ali A Moosavi-Movahed; Hassan Vatandoost; Mofid Gorji-Bandpy; Bahram Mobasher; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge.

Authors:  Nima Rezaei; Saboura Ashkevarian; Mahsa Keshavarz Fathi; Sara Hanaei; Zahra Kolahchi; Seyedeh-Sanam Ladi Seyedian; Elham Rayzan; Mojdeh Sarzaeim; Aida Vahed; Kawthar Mohamed; Sarah Momtazmanesh; Negar Moradian; Zahra Rahimi Pirkoohi; Noosha Sameeifar; Mahsa Yousefpour; Sepideh Sargoli; Saina Adiban; Aida Vahed; Niloufar Yazdanpanah; Heliya Ziaei; Amene Saghazadeh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Coronavirus: Pure Infectious Disease or Genetic Predisposition.

Authors:  Farzaneh Darbeheshti; Hassan Abolhassani; Mohammad Bashashati; Saeid Ghavami; Sepideh Shahkarami; Samaneh Zoghi; Sudhir Gupta; Jordan S Orange; Hans D Ochs; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions.

Authors:  Shirin Moossavi; Kelsey Fehr; Hassan Maleki; Simin Seyedpour; Mahdis Keshavarz-Fathi; Farhad Tabasi; Mehrdad Heravi; Rayka Sharifian; Golnaz Shafiei; Negin Badihian; Roya Kelishadi; Shahrzad Nematollahi; Majid Almasi; Saskia Popescu; Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the COVID-19 Pandemic.

Authors:  Helia Mojtabavi; Nasirudin Javidi; Anne-Frédérique Naviaux; Pascal Janne; Maximilien Gourdin; Mahsa Mohammadpour; Amene Saghazadeh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Clinical Manifestations of COVID-19.

Authors:  Mahsa Eskian; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.